Thereby unveiling a higher margin & (supposedly) faster growth company, focusing on: i) sales, marketing & healthcare communications services, and ii) pharmaceutical contract
packaging & clinical trials materials — all intended to exploit the
ongoing trend for healthcare companies to outsource non-core & specialist activities on an international basis.